📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Durect

1.1 - Company Overview

Durect Logo

Durect

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical drug development focused on pain and chronic diseases, with late-stage programs including REMOXY, POSIDUR, ELADUR, and TRANSDUR-Sufentanil, leveraging proprietary oral, transdermal and injectable depot delivery technologies to enable new indications.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Durect

MILabs Logo

MILabs

HQ: The Netherlands Website
  • Description: Provider of high-end molecular imaging solutions for biomedical research, including systems for quantitative 3D functional imaging of SPECT (U-SPECT) and PET (U-PET) tracers, an integrated PET/SPECT platform for simultaneous high-resolution imaging (VECTor), and automated quantitative 3D autoradiography of tissue samples with multiple isotopes (EXIRAD-3D).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MILabs company profile →
Molecular Devices Logo

Molecular Devices

HQ: United States Website
  • Description: Provider of analytical solutions for cell and protein biology, enabling customers to unravel complex biological systems. Offerings include AI-driven automated cell culture (CellXpress.ai), high-content confocal imaging (ImageXpress), SpectraMax microplate readers, SoftMax Pro software for data analysis, GxP compliance solutions, and an Organoid Innovation Center for 3D biological models.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Molecular Devices company profile →
ActivX Biosciences Logo

ActivX Biosciences

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery and development of highly selective, best-in-class small molecule drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ActivX Biosciences company profile →
Alphalyse Logo

Alphalyse

HQ: Denmark Website
  • Description: Provider of protein chemistry, bioinformatics, and mass spectrometry services for biopharma, biotech companies, and universities, including host cell protein analysis, recombinant protein and monoclonal antibody characterization, advanced therapies and vaccine analysis, LC-MS HCP assay validation and GMP release testing, and GMP-validated MS-based residual enzyme analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alphalyse company profile →
Peloton Therapeutics Logo

Peloton Therapeutics

HQ: United States Website
  • Description: Provider of cancer drug discovery and development based in Dallas. Offers a clinical-stage small-molecule HIF-2α inhibitor targeting hypoxia-inducible factor-2α for kidney cancer and other disorders, and research programs to discover compounds that modulate disease-driving protein-protein interactions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Peloton Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Durect

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Durect

2.2 - Growth funds investing in similar companies to Durect

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Durect

4.2 - Public trading comparable groups for Durect

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Durect

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Durect

What does Durect do?

Durect is a provider of specialty pharmaceutical drug development focused on pain and chronic diseases, with late-stage programs including REMOXY, POSIDUR, ELADUR, and TRANSDUR-Sufentanil, leveraging proprietary oral, transdermal and injectable depot delivery technologies to enable new indications.

Who are Durect's competitors?

Durect's competitors and similar companies include MILabs, Molecular Devices, ActivX Biosciences, Alphalyse, and Peloton Therapeutics.

Where is Durect headquartered?

Durect is headquartered in United States.

How many employees does Durect have?

Durect has 1,000 employees 🔒.

When was Durect founded?

Durect was founded in 2010 🔒.

What sector and industry vertical is Durect in?

Durect is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Durect

Who are the top strategic acquirers in Durect's sector and industry

Top strategic M&A buyers and acquirers in Durect's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Durect?

Top strategic M&A buyers groups and sectors for Durect include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Durect's sector and industry vertical

Which are the top PE firms investing in Durect's sector and industry vertical?

Top PE firms investing in Durect's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Durect's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Durect's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Durect's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Durect include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Durect's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Durect?

The key public trading comparables and valuation benchmarks for Durect include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Durect for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Durect with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Durect's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Durect with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Durect's' sector and industry vertical?

Access recent funding rounds and capital raises in Durect's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Durect